Suppr超能文献

终末期肝病模型(MELD)时代老年肝移植受者的预后。

Outcomes among older adult liver transplantation recipients in the model of end stage liver disease (MELD) era.

作者信息

Malinis Maricar F, Chen Shu, Allore Heather G, Quagliarello Vincent J

机构信息

Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, USA.

Section of Geriatrics, Department of Internal Medicine, Yale School of Medicine, New Haven, USA.

出版信息

Ann Transplant. 2014 Sep 26;19:478-87. doi: 10.12659/AOT.890934.

Abstract

BACKGROUND

Since 2002, the Model of End Stage Liver Disease (MELD) score has been the basis of the liver transplant (LT) allocation system. Among older adult LT recipients, short-term outcomes in the MELD era were comparable to the pre-MELD era, but long-term outcomes remain unclear.

MATERIAL AND METHODS

This is a retrospective cohort study using the UNOS data on patients age ≥ 50 years who underwent primary LT from February 27, 2002 until October 31, 2011.

RESULTS

A total of 35,686 recipients met inclusion criteria. The cohort was divided into 5-year interval age groups. Five-year over-all survival rates for ages 50-54, 55-59, 60-64, 65-69, and 70+ were 72.2%, 71.6%, 69.5%, 65.0%, and 57.5%, respectively. Five-year graft survival rates after adjusting for death as competing risk for ages 50-54, 55-59,60-64, 65-69 and 70+ were 85.8%, 87.3%, 89.6%, 89.1% and 88.9%, respectively. By Cox proportional hazard modeling, age ≥ 60, increasing MELD, donor age ≥ 60, hepatitis C, hepatocellular carcinoma (HCC), dialysis and impaired pre-transplant functional status (FS) were associated with increased 5-year mortality. Using Fine and Gray sub-proportional hazard modeling adjusted for death as competing risk, 5-year graft failure was associated with donor age ≥ 60, increasing MELD, hepatitis C, HCC, and impaired pre-transplant FS.

CONCLUSIONS

Among older LT recipients in the MELD era, long-term graft survival after adjusting for death as competing risk was improved with increasing age, while over-all survival was worse. Donor age, hepatitis C, and pre-transplant FS represent potentially modifiable risk factors that could influence long-term graft and patient survival.

摘要

背景

自2002年以来,终末期肝病模型(MELD)评分一直是肝移植(LT)分配系统的基础。在老年LT受者中,MELD时代的短期结局与MELD时代之前相当,但长期结局仍不明确。

材料与方法

这是一项回顾性队列研究,使用了器官共享联合网络(UNOS)关于2002年2月27日至2011年10月31日期间接受初次LT的年龄≥50岁患者的数据。

结果

共有35686名受者符合纳入标准。该队列被分为5年间隔的年龄组。50 - 54岁、55 - 59岁、60 - 64岁、65 - 69岁和70岁及以上年龄组的5年总生存率分别为72.2%、71.6%、69.5%、65.0%和57.5%。将死亡作为竞争风险进行调整后,50 - 54岁、55 - 59岁、60 - 64岁、65 - 69岁和70岁及以上年龄组的5年移植物生存率分别为85.8%、87.3%、89.6%、89.1%和88.9%。通过Cox比例风险模型,年龄≥60岁、MELD升高、供体年龄≥60岁、丙型肝炎、肝细胞癌(HCC)、透析以及移植前功能状态(FS)受损与5年死亡率增加相关。使用将死亡作为竞争风险进行调整的Fine和Gray亚比例风险模型,5年移植物失败与供体年龄≥60岁、MELD升高、丙型肝炎、HCC以及移植前FS受损相关。

结论

在MELD时代的老年LT受者中,将死亡作为竞争风险进行调整后,随着年龄增长,长期移植物生存率提高,而总生存率更差。供体年龄、丙型肝炎和移植前FS是可能影响长期移植物和患者生存的潜在可改变风险因素。

相似文献

2
Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
Transplant Proc. 2016 Dec;48(10):3362-3367. doi: 10.1016/j.transproceed.2016.08.044.
3
Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
J Hepatol. 2022 Mar;76(3):619-627. doi: 10.1016/j.jhep.2021.10.024. Epub 2021 Nov 10.
9
Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
Transplantation. 2016 Jan;100(1):141-6. doi: 10.1097/TP.0000000000000829.
10
Improved posttransplant mortality after share 35 for liver transplantation.
Hepatology. 2018 Jan;67(1):273-281. doi: 10.1002/hep.29301. Epub 2017 Nov 13.

引用本文的文献

3
The liver frailty index is a predictor of healthcare utilization after liver transplantation in older adults.
Clin Transplant. 2024 Jan;38(1):e15219. doi: 10.1111/ctr.15219. Epub 2023 Dec 8.
4
Clinical Characteristics Associated With Posttransplant Survival Among Adults 70 Years Old or Older Undergoing Liver Transplantation.
J Clin Gastroenterol. 2024;58(5):516-521. doi: 10.1097/MCG.0000000000001870. Epub 2023 Jun 7.
5
Outcomes of Geriatric Patients with Hepatocellular Carcinoma.
Curr Oncol. 2022 Jun 16;29(6):4332-4341. doi: 10.3390/curroncol29060346.
6
Solid organ transplantation in older adults. Infectious and other age-related considerations.
OBM Transplant. 2019 Nov;3(1). doi: 10.21926/obm.transplant.1901046. Epub 2019 Feb 1.
7
Transplant of Elderly Patients: Is There an Upper Age Cutoff?
Clin Liver Dis. 2021 Feb;25(1):209-227. doi: 10.1016/j.cld.2020.09.001. Epub 2020 Oct 21.
8
Living Donor Liver Transplant in Patients Aged 60 Years or Older: Experience from a Large Volume Centre in India.
J Clin Exp Hepatol. 2021 Jan-Feb;11(1):3-8. doi: 10.1016/j.jceh.2020.07.007. Epub 2020 Jul 18.
10
Differential Impact of Age Among Liver Transplant Candidates With and Without Hepatocellular Carcinoma.
Liver Transpl. 2020 Mar;26(3):349-358. doi: 10.1002/lt.25662. Epub 2019 Nov 20.

本文引用的文献

2
Exercise training in solid organ transplant recipients: a systematic review and meta-analysis.
Transplantation. 2013 Mar 15;95(5):679-87. doi: 10.1097/TP.0b013e31827a3d3e.
3
Efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis C.
Aliment Pharmacol Ther. 2013 Jan;37(1):81-90. doi: 10.1111/apt.12112. Epub 2012 Nov 5.
5
Solid-organ transplantation in older adults: current status and future research.
Am J Transplant. 2012 Oct;12(10):2608-22. doi: 10.1111/j.1600-6143.2012.04245.x. Epub 2012 Sep 7.
8
Increased susceptibility to liver fibrosis with age is correlated with an altered inflammatory response.
Rejuvenation Res. 2011 Aug;14(4):353-63. doi: 10.1089/rej.2010.1146. Epub 2011 May 6.
9
Variation in organ quality between liver transplant centers.
Am J Transplant. 2011 May;11(5):958-64. doi: 10.1111/j.1600-6143.2011.03487.x. Epub 2011 Apr 5.
10
Competing risk of death: an important consideration in studies of older adults.
J Am Geriatr Soc. 2010 Apr;58(4):783-7. doi: 10.1111/j.1532-5415.2010.02767.x. Epub 2010 Mar 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验